AGRX — Agile Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.43m
- $7.58m
- $19.59m
Agile Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Reorganization Of Leadership Team
Brief: Agile Therapeutics Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Agile Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Agile Therapeutics Reports Q2 Loss Per Share $2.71
Agile Therapeutics Inc expected to post a loss of $3.70 a share - Earnings Preview
Agile Therapeutics up after Maxim raises rating to "buy"
Brief: Agile Therapeutics Updates Second Quarter 2022 Guidance
U.S. STOCKS ON THE MOVE-Kohl's, chipmakers, EV stocks
Contraceptive maker Agile hits record low on upsized share offering
U.S. abortion ruling ignites retail interest in women contraceptive makers - Vanda
Brief: Agile Therapeutics Announces Pricing Of $24 Mln Upsized Public Offering
Brief: Agile Therapeutics Files For Offering Up To 15.7 Million Shares Of Common Stock, Together With Series A-1 Warrants And Series A-2 Warrants
Brief: Agile Therapeutics CFO Notified Co That He Will Voluntarily Resign To Retire
Agile Therapeutics Inc expected to post a loss of $4.80 a share - Earnings Preview
Brief: Agile Therapeutics Inc Says Entered Into Agreement To Offer And Sell Shares Of Up To $12.8 Mln - SEC Filing
Agile Therapeutics surges ahead of reverse stock split
Brief: Agile Therapeutics Reports 1-For-40 Reverse Stock Split
Brief: Agile Therapeutics Says In Q1 2022 Twirla Cycles Dispensed Increased 29% To 16,602